Builders #30 w/ Sekar Kathiresan M.D. - Co-Founder & CEO @ Verve Therapeutics | BIOS
Guest: Sekar Kathiresan M.D. - Co-Founder & CEO @ Verve Therapeutics Sekar Kathiresan is co-founder and chief executive officer of Verve Therapeutics. He is also a member of the company’s board of directors. Dr. Kathiresan is a preventive cardiologist who has made groundbreaking discoveries of cardioprotective genetic mutations, which confer resistance to cardiovascular disease. Prior to joining Verve, he served as director of the Massachusetts General Hospital (MGH) Center for Genomic Medicine and was the Ofer and Shelly Nemirovsky MGH Research Scholar. He also served as director of the Cardiovascular Disease Initiative at the Broad Institute and was professor of medicine at Harvard Medical School. Dr. Kathiresan’s research laboratory focused on understanding the inherited basis for blood lipids and myocardial infarction and using these insights to improve preventive cardiac care. Among his scientific contributions, Dr. Kathiresan has helped highlight new biological mechanisms underlying heart attack, discovered mutations that protect against heart attack risk, and developed a genetic test for personalized heart attack prevention. For his research contributions, he has been honored with a Distinguished Scientist Award from the American Heart Association and the 2018 Curt Stern Award from the American Society of Human Genetics. In tandem with his research, his clinical focus was the primary prevention of myocardial infarction in individuals with a family history of heart attack. Dr. Kathiresan graduated summa cum laude with a B.A. in history from the University of Pennsylvania and received his M.D. from Harvard Medical School. He completed his clinical training in internal medicine and cardiology at MGH and his postdoctoral research training in human genetics at the Framingham Heart Study and the Broad Institute. Host: Drew Yashar _______________________ Join BIOS Community 🎉 Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only events… Apply to Join —https://docs.google.com/forms/d/e/1FA... For More Interesting Content 💭 🦾 Website: https://www.bios.community/ 🧬 Podcast: https://open.spotify.com/show/2HmcPq9... 🧪 Medium: / bios 🩺 Twitter: / bios_community 🦠 LinkedIn: / bios-community 🧠 Substack: https://bioscommunity.substack.com _______________________ BIOS: Nucleus of Life Science Innovation 🚀 Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Create Radical Advances in Human Health🌟

Tempus AI CEO Eric Lefkosky

Builders #27 w/ Keith Gottesdiener - President & CEO @ Prime Medicine | BIOS

From Reading the Genome for Risk to Rewriting it for Cardiovascular Health | Sekar Kathiresan, MD

Spine Surgeon Drowns for 30 Minutes —Comes Back With a List

How I Use Statins to Unclog Arteries

Exposing Why Farmers Can't Legally Replant Their Own Seeds

How Repeatable Systems Help Advisors Scale Without Working More - June 8 @12

The Gene-Editing Revolution with Verve Therapeutics

Before You Panic Over Your DEXA Score, Watch THIS

Why Does MASS Create Gravity? The Answer Will DESTROY Your Understanding of Reality

Golden Retriever Meets Completely Broken Rescue for the First Time

How to eat to lower your cholesterol in 10 days | Prof. Sarah Berry

Builders #33 w/ Oguzhan Atay - Co-Founder & CEO @ BillionToOne | BIOS

FULL DISCUSSION: Google's Demis Hassabis, Anthropic's Dario Amodei Debate the World After AGI | AI1G

Atrial Fibrillation: New Solutions for an Old Problem

AI for Inclusion: New Tools for Disability Rights and Civic Participation

aTyr Pharma, Inc. (Nasdaq: ATYR) — Life Sciences Virtual Investor Forum 2026

Think Fast, Talk Smart: Communication Techniques

The Longevity Revolution Is Here | Lifespan with Dr. David Sinclair - Season 2, Episode 1

